杨贵妃传媒視頻

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Medicaid Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • 杨贵妃传媒視頻 Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • High Postcancer Medical Bills
  • Federal Workers’ Health Data
  • Cyberattacks on Hospitals
  • ‘Cheap’ Insurance

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Apr 23 2020

Full Issue

Experts Caution Vaccine Agency Director's Ousting Could Be Troubling Trend For Scientists Who Disagree With Trump

Rick Bright, the former director of the Biomedical Advanced Research and Development Authority, claims that his ousting is due to his comments about hydroxychloroquine, a drug that President Donald Trump touted prematurely as a "game changer." Democrats have called for an investigation into Bright's removal, as some experts worry his removal is part of a bigger trend of retaliation against scientists who don't fall in line.

Rick Bright, the U.S. official who was ousted this week from a post atop an agency charged with developing vaccines, has decided to put the Trump administration on trial. The charge: politicizing science. (Florko, 4/22)

The head of a government agency combating the coronavirus pandemic alleged Wednesday that he was ousted for opposing politically connected efforts to promote a malaria drug that President Donald Trump touted without proof as a remedy for COVID-19. Rick Bright, former director of the Biomedical Advanced Research and Development Authority, said in a statement that he was summarily removed from his job on Tuesday and reassigned to a lesser role. His lawyers, Debra Katz and Lisa Banks, called it 鈥渞etaliation plain and simple.鈥 (Alonso-Zaldivar, 4/23)

鈥淲hile I am prepared to look at all options and to think 鈥榦utside the box鈥 for effective treatments, I rightly resisted efforts to provide an unproven drug on demand to the American public,鈥 Bright said in the statement, reported by multiple U.S. media outlets on Wednesday. Bright said the U.S. government has promoted the medicines as a 鈥減anacea鈥 even though they 鈥渃learly lack scientific merit.鈥 (Wolfe, 4/22)

Bright said his career in vaccine development has prepared him for a crisis like this one. "To this point, I have led the government's efforts to invest in the best science available to combat the COVID-19 pandemic," he said. "Unfortunately, this resulted in clashes with HHS political leadership, including criticism for my proactive efforts to invest early in vaccines and supplies critical to saving American lives. I also resisted efforts to fund potentially dangerous drugs promoted by those with political connections." (Swasey, 4/22)

In a comment late Wednesday evening, HHS spokeswoman Caitlin Oakley pushed back on Dr. Bright鈥檚 assertion that he opposed the use of hydroxychloroquine. 鈥淚t was Dr. Bright who requested an Emergency Use Authorization (EUA) from the FDA for donations of chloroquine that Bayer and Sandoz recently made to the Strategic National Stockpile for use on Covid-19 patients,鈥 she said. 鈥淭he EUA is what made the donated product available for use in combating Covid-19.鈥 Mr. Trump, asked at Wednesday鈥檚 briefing about Dr. Bright鈥檚 claim he was pushed out in part due to his opposition to hydroxychloroquine, said, 鈥淚鈥檝e never heard of him.鈥 (Ballhaus and Armour, 4/22)

Sen. Ed Markey (D-Mass.) on Wednesday called for an investigation into the removal of the former director of the federal office that will be at the forefront of developing a COVID-19 cure. Markey鈥檚 push for an investigation came after Rick Bright, the聽former director of the Biomedical Advanced Research and Development Authority (BARDA), said he was forced out of the position for prioritizing science over promoting unproven treatments President Trump had repeatedly pushed as potential cures without evidence. (Klar, 4/22)

Alarming new signs are emerging that the Trump administration is shunting science aside in the battle against coronavirus. In Wednesday's most stunning development, a top administration official working on a vaccine claimed he was ousted after resisting efforts to push unproven drugs promoted by President Donald Trump and his conservative media cheerleaders as "game changer" treatments. (Collinson, 4/23)

Robert Redfield, director of the Centers for Disease Control and Prevention, issued a candid warning Tuesday in a Washington Post interview: A simultaneous flu and coronavirus outbreak next fall and winter 鈥渨ill actually be even more difficult than the one we just went through,鈥 adding that calls and protests to 鈥渓iberate鈥 states from stay-at-home orders 鈥 as President Trump has tweeted 鈥 were 鈥渘ot helpful.鈥 The next morning, Trump cracked down with a Twitter edict: Redfield had been totally misquoted in a cable news story summarizing the interview, he claimed, and would be putting out a statement shortly. (Parker, Dawsey, Abutaleb and Sun, 4/22)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Wednesday, April 22
  • Tuesday, April 21
  • Monday, April 20
  • Friday, April 17
  • Thursday, April 16
  • Wednesday, April 15
More Morning Briefings
RSS Feeds
  • 杨贵妃传媒視頻
  • Special Reports
  • Morning Briefing
  • About Us
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

漏 2026 KFF